Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Steven Kleinman
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Procedures
Organizations
Chemicals & Drugs
Disorders
Geographic Areas
Phenomena
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
22
Busch, Michael
21
Glynn, Simone
18
Schreiber, George
12
Wright, David
10
Williams, AE
9
Tobler, Leslie
9
Stramer, Susan
9
Nemo, George
8
Ownby, Helen
7
Murphy, Edward
6
Nass, Catharie
6
Caglioti, Sally
5
Busch, Michael
5
Gilcher, Ronald
5
Operskalski, Eva
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Steven Kleinman (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Kleinman Steven H; Williams Joan Dunn; Robertson Gene; Caglioti Sally; Williams Robert C; Spizman Randall; Morgan Larry; Tomasulo Peter; Busch Michael P
West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.
Transfusion 2009;49(6):1160-70.
-
2009: Kleinman Steven; Dumont Larry J; Tomasulo Peter; Bianco Celso; Katz Louis; Benjamin Richard J; Gajic Ognjen; Brecher Mark E
The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments.
Transfusion 2009;49(5):903-12.
-
2009: Norris Philip J; Lee Jar-How; Carrick Danielle M; Gottschall Jerome L; Lebedeva Mila; de Castro B R; Kleinman Steven H; Busch Michael P
Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma.
Transfusion 2009;49(2):243-51.
-
2008: Busch Michael P; Kleinman Steven H; Tobler Leslie H; Kamel Hany T; Norris Philip J; Walsh Irina; Matud Jose L; Prince Harry E; Lanciotti Robert S; Wright David J; Linnen Jeffrey M; Caglioti Sally
Virus and antibody dynamics in acute west nile virus infection.
The Journal of infectious diseases 2008;198(7):984-93.
-
2008: Pai Anuradha; Kleinman Steven; Malhotra Khushbeer; Lee-Haynes Lorlelei; Pietrelli Larry; Saldanha John
Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay.
Transfusion 2008;48(10):2184-9.
-
2007: Kleinman Steven H; Glynn Simone A; Lee Tzong-Hae; Tobler Leslie; Montalvo Leilani; Todd Deborah; Kiss Joseph E; Shyamala Venkatakrishna; Busch Michael P;
Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Transfusion 2007;47(10):1756-64.
-
2006: Kleinman Steven H; Kamel Hany T; Harpool Dennis R; Vanderpool Sandra K; Custer Brian; Wiltbank Thomas B; Nguyen Kim-Anh; Tomasulo Peter A
Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets.
Transfusion 2006;46(10):1787-94.
-
2006: Kleinman Steven H; Stramer Susan L; Brodsky Jaye P; Caglioti Sally; Busch Michael P
Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
Transfusion 2006;46(5):695-702.
-
2006: Busch Michael P; Wright David J; Custer Brian; Tobler Leslie H; Stramer Susan L; Kleinman Steven H; Prince Harry E; Bianco Celso; Foster Gregory; Petersen Lyle R; Nemo George; Glynn Simone A
West Nile virus infections projected from blood donor screening data, United States, 2003.
Emerging infectious diseases 2006;12(3):395-402.
-
2006: Busch Michael P; Glynn Simone A; Stramer Susan L; Orland Jennie; Murphy Edward L; Wright David J; Kleinman Steven;
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Transfusion 2006;46(3):469-75.
-
2005: Busch Michael P; Glynn Simone A; Wright David J; Hirschkorn Dale; Laycock Megan E; McAuley Joan; Tu Yongling; Giachetti Cristina; Gallarda James; Heitman John; Kleinman Steven H;
Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Transfusion 2005;45(12):1853-63.
-
2005: Busch Michael P; Caglioti Sally; Robertson Eugene F; McAuley Joan D; Tobler Leslie H; Kamel Hany; Linnen Jeffrey M; Shyamala Venkatakrishna; Tomasulo Peter; Kleinman Steven H
Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
The New England journal of medicine 2005;353(5):460-7.
-
2005: Kleinman S H; Strong D M; Tegtmeier G G E; Holland P V; Gorlin J B; Cousins C; Chiacchierini R P; Pietrelli L A
Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
Transfusion 2005;45(8):1247-57.
-
2005: Wang Baoguang; Schreiber G B; Glynn S A; Kleinman Steven; Wright D J; Murphy E L; Busch M P;
Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
Transfusion 2005;45(7):1089-96.
-
2005: Kleinman S H; Glynn S A; Higgins M J; Triulzi D J; Smith J W; Nass C C; Garratty George; Murphy E L; LeParc G F; Schreiber G B; King M R; Chamberland M E; Nemo G J
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.
Transfusion 2005;45(7):1073-83.
-
2005: Glynn Simone A; Wright David J; Kleinman Steven H; Hirschkorn Dale; Tu Yongling; Heldebrant Charles; Smith Richard; Giachetti Cristina; Gallarda James; Busch Michael P
Dynamics of viremia in early hepatitis C virus infection.
Transfusion 2005;45(6):994-1002.
-
2005: Busch M P; Tobler L H; Saldanha J; Caglioti S; Shyamala V; Linnen J M; Gallarda J; Phelps B; Smith R I F; Drebot M; Kleinman S H
Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.
Transfusion 2005;45(4):492-9.
-
2005: Tobler L H; Bianco C; Glynn S A; Schreiber G B; Dille B J; Prince H E; Lanciotti R S; Linnen J M; Gallarda J; Shyamala V; Smith D; Kleinman S H; Busch M P;
Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
Transfusion 2005;45(4):480-6.
-
2005: Kleinman Steven; Glynn Simone A; Busch Michael; Todd Deborah; Powell Laurie; Pietrelli Larry; Nemo George; Schreiber George; Bianco Celso; Katz Louis;
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
Transfusion 2005;45(4):469-79.
-
2005: Busch Michael P; Glynn Simone A; Stramer Susan L; Strong D Michael; Caglioti Sally; Wright David J; Pappalardo Brandee; Kleinman Steven H;
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
Transfusion 2005;45(2):254-64.
-
2005: Kleinman S; Katz L
Initiatives to improve blood donor screening.
Developments in biologicals 2005;120():67-75.
-
2004: Kleinman Steven; Caulfield Tim; Chan Penny; Davenport Robertson; McFarland Janice; McPhedran Susan; Meade Maureen; Morrison Douglas; Pinsent Thomas; Robillard Pierre; Slinger Peter
Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel.
Transfusion 2004;44(12):1774-89.
-
2004: Robillard Pierre; Chan Penny; Kleinman Steve
Hemovigilance for improvement of blood safety.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2004;31(2):95-8.
-
2004: Kuhns Mary C; Kleinman Steven H; McNamara Anne L; Rawal Bhupat; Glynn Simone; Busch Michael P;
Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Transfusion 2004;44(9):1332-9.
-
2004: Stramer Susan L; Glynn Simone A; Kleinman Steven H; Strong D Michael; Caglioti Sally; Wright David J; Dodd Roger Y; Busch Michael P;
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
The New England journal of medicine 2004;351(8):760-8.
-
2004: Wang B; Higgins M J; Kleinman S; Schreiber G B; Murphy E L; Glynn S A; Wright D J; Nass C C; Chang D; Busch M P;
Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.
Transfusion 2004;44(8):1243-51.
-
2003: Tobler Leslie H; Stramer Susan L; Lee Stephen R; Masecar Barbara L; Peterson Jon E; Davis E Anne; Andrews William E; Brodsky Jaye P; Kleinman Steven H; Phelps Bruce H; Busch Michael P
Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
Transfusion 2003;43(10):1452-9.
-
2003: Fiebig Eberhard W; Wright David J; Rawal Bhupat D; Garrett Patricia E; Schumacher Richard T; Peddada Lorraine; Heldebrant Charles; Smith Richard; Conrad Andrew; Kleinman Steven H; Busch Michael P
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.
AIDS (London, England) 2003;17(13):1871-9.
-
2003: Kleinman Steven H; Kuhns Mary C; Todd Deborah S; Glynn Simone A; McNamara Anne; DiMarco Anthony; Busch Michael P;
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening.
Transfusion 2003;43(6):696-704.
-
2003: Kleinman Steven; Chan Penny; Robillard Pierre
Risks associated with transfusion of cellular blood components in Canada.
Transfusion medicine reviews 2003;17(2):120-62.
-
2003: Busch Michael P; Kleinman Steven H; Nemo George J
Current and emerging infectious risks of blood transfusions.
JAMA : the journal of the American Medical Association 2003;289(8):959-62.
-
2003: Sharma Usha K; Stramer Susan L; Wright David J; Glynn Simone A; Hermansen Sigurd; Schreiber George B; Kleinman Steven H; Busch Michael P;
Impact of changes in viral marker screening assays.
Transfusion 2003;43(2):202-14.
-
2003: Glynn Simone A; Williams Alan E; Nass Catharie C; Bethel James; Kessler Debra; Scott Edward P; Fridey Joy; Kleinman Steven H; Schreiber George B;
Attitudes toward blood donation incentives in the United States: implications for donor recruitment.
Transfusion 2003;43(1):7-16.
-
2002: Tobler L H; Dockter Janel; Stramer S L; Kleinman S H; Todd D; Giachetti Cristina; Busch M P
Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood.
Transfusion 2002;42(11):1525-7.
-
2001: Tobler L H; Stramer S L; Kleinman S H; Brodsky J P; Todd D S; Busch M P
Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity.
Transfusion 2001;41(12):1625-6.
-
2001: Kleinman S
Hepatitis G virus biology, epidemiology, and clinical manifestations: Implications for blood safety.
Transfusion medicine reviews 2001;15(3):201-12.
-
2001: Glynn S A; Smith J W; Schreiber G B; Kleinman S H; Nass C C; Bethel J; Biswas B; Thomson R A; Williams A E;
Repeat whole-blood and plateletpheresis donors:unreported deferrable risks, reactive screening tests, andresponse to incentive programs.
Transfusion 2001;41(6):736-43.
-
2001: Schreiber G B; Glynn S A; Busch M P; Sharma U K; Wright D J; Kleinman S H;
Incidence rates of viral infections among repeat donors:are frequent donors safer?
Transfusion 2001;41(6):730-5.
-
2000: Glynn S A; Kleinman S H; Schreiber G B; Busch M P; Wright D J; Smith J W; Nass C C; Williams A E
Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)
JAMA : the journal of the American Medical Association 2000;284(2):229-35.
-
2000: Kleinman S
Residual risk of transfusion transmitted viral infections among seronegative donors: application of the incidence/window period model.
Developments in biologicals 2000;102():61-5.
-
1999: Busch M; Chamberland M; Epstein J; Kleinman S; Khabbaz R; Nemo G
Oversight and monitoring of blood safety in the United States.
Vox sanguinis 1999;77(2):67-76.
-
1998: Kleinman S; Williams A E
Donor selection procedures: is it possible to improve them?
Transfusion medicine reviews 1998;12(4):288-302.
-
1998: Kleinman S; Busch M P; Hall L; Thomson R; Glynn S; Gallahan D; Ownby H E; Williams A E
False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study.
JAMA : the journal of the American Medical Association 1998;280(12):1080-5.
-
1998: Glynn S A; Schreiber G B; Busch M P; Kleinman S H; Williams A E; Nass C C; Ownby H E; Smith J W
Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study.
Transfusion 1998;38(4):350-8.
-
1997: Kleinman S; Busch M P; Korelitz J J; Schreiber G B
The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.
Transfusion medicine reviews 1997;11(3):155-72.
-
1997: Korelitz J J; Busch M P; Kleinman S H; Williams A E; Gilcher R O; Ownby H E; Schreiber G B
A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study.
Transfusion 1997;37(6):634-40.
-
1997: Williams A E; Thomson R A; Schreiber G B; Watanabe K; Bethel J; Lo A; Kleinman S H; Hollingsworth C G; Nemo G J
Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study.
JAMA : the journal of the American Medical Association 1997;277(12):967-72.
-
1997: Ownby H E; Korelitz J J; Busch M P; Williams A E; Kleinman S H; Gilcher R O; Nourjah P
Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Retrovirus Epidemiology Donor Study.
Transfusion 1997;37(2):199-205.
-
1996: Kaplan J E; Khabbaz R F; Murphy E L; Hermansen S; Roberts C; Lal R; Heneine W; Wright D; Matijas L; Thomson R; Rudolph D; Switzer W M; Kleinman S; Busch M; Schreiber G B
Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(2):193-201.
-
1996: Schreiber G B; Busch M P; Kleinman S H; Korelitz J J
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
The New England journal of medicine 1996;334(26):1685-90.
-
1996: Murphy E L; Bryzman S; Williams A E; Co-Chien H; Schreiber G B; Ownby H E; Gilcher R O; Kleinman S H; Matijas L; Thomson R A; Nemo G J
Demographic determinants of hepatitis C virus seroprevalence among blood donors.
JAMA : the journal of the American Medical Association 1996;275(13):995-1000.
-
1996: Korelitz J J; Busch M P; Kleinman S H; Williams A E; Zuck T F; Gilcher R O; Ownby H E; Co Chien H; Nemo G J
Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors.
Transfusion 1996;36(3):232-7.
-
1996: Busch M P; Kleinman S H; Williams A E; Smith J W; Ownby H E; Laycock M E; Lee L L; Pau C P; Schreiber G B
Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
Transfusion 1996;36(1):37-44.
-
1995: Zuck T F; Thomson R A; Schreiber G B; Gilcher R O; Kleinman S H; Murphy E L; Ownby H E; Williams A E; Busch M P; Smith J W
The Retrovirus Epidemiology Donor Study (REDS): rationale and methods.
Transfusion 1995;35(11):944-51.
-
1995: Busch M P; Korelitz J J; Kleinman S H; Lee S R; AuBuchon J P; Schreiber G B
Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.
Transfusion 1995;35(11):903-10.
-
1994: Busch M P; Operskalski E A; Mosley J W; Stevens C E; Schiff E R; Kleinman S H; Lee H; Lee M; Harris M
Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group.
Transfusion 1994;34(10):858-64.
-
1994: Donegan E; Lee H; Operskalski E A; Shaw G M; Kleinman S H; Busch M P; Stevens C E; Schiff E R; Nowicki M J; Hollingsworth C G
Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.
Transfusion 1994;34(6):478-83.
-
1994: Busch M P; Laycock M; Kleinman S H; Wages J W; Calabro M; Kaplan J E; Khabbaz R F; Hollingsworth C G
Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
Blood 1994;83(4):1143-8.
-
1993: Kleinman S; Swanson P; Allain J P; Lee H
Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations.
Transfusion 1993;33(1):14-8.
-
1992: Kleinman S; Alter H; Busch M; Holland P; Tegtmeier G; Nelles M; Lee S; Page E; Wilber J; Polito A
Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay.
Transfusion 1992;32(9):805-13.
-
1991: Busch M P; Guiltinan A; Skettino S; Cordell R; Zeger G; Kleinman S
Safety of blood donations following a natural disaster.
Transfusion 1991;31(8):719-23.
-
1991: Prince H E; Lee H; Jensen E R; Swanson P; Weber D; Fitzpatrick L; Doyle M; Kleinman S
Immunologic correlates of spontaneous lymphocyte proliferation in human T-lymphotropic virus infection.
Blood 1991;78(1):169-74.
-
1990: Donegan E; Stuart M; Niland J C; Sacks H S; Azen S P; Dietrich S L; Faucett C; Fletcher M A; Kleinman S H; Operskalski E A
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.
Annals of internal medicine 1990;113(10):733-9.
-
1990: Busch M P; Taylor P E; Lenes B A; Kleinman S H; Stuart M; Stevens C E; Tomasulo P A; Allain J P; Hollingsworth C G; Mosley J W
Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group.
The New England journal of medicine 1990;323(19):1308-12.
-
1990: Kleinman S
The significance of HIV-1-indeterminate western blot results in blood donor populations.
Archives of pathology & laboratory medicine 1990;114(3):298-303.
-
1989: Operskalski E A; Schiff E R; Kleinman S H; Busch M; Taylor P E; Parks W P; Lee H; Tomasulo P A; Donegan E; Stuart M
Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion Safety Study Group.
Transfusion 1989;29(8):746-8.
-
1989: Kleinman S H; Niland J C; Azen S P; Operskalski E A; Barbosa L H; Chernoff A I; Edwards V M; Lenes B A; Marshall G J; Nemo G J
Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository.
Transfusion 1989;29(7):572-80.
-
1988: Kleinman S; Secord K
Risk of human immunodeficiency virus (HIV) transmission by anti-HIV negative blood. Estimates using the lookback methodology.
Transfusion 1988;28(5):499-501.
-
1988: Kleinman S; Fitzpatrick L; Secord K; Wilke D
Follow-up testing and notification of anti-HIV Western blot atypical (indeterminant) donors.
Transfusion 1988;28(3):280-2.
-
1988: Ward J W; Holmberg S D; Allen J R; Cohn D L; Critchley S E; Kleinman S H; Lenes B A; Ravenholt O; Davis J R; Quinn M G
Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.
The New England journal of medicine 1988;318(8):473-8.
Sign-in to see more
